Latest News and Press Releases

Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as part of global trial Investigational single-pill combination offers potential to...

George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director London, UK, 12 July 2021 – George Medicines, a late-stage drug development company focused on providing innovative and...

George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director London, UK, 12 July 2021 – George Medicines, a late-stage drug development company focused on providing innovative and...

George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...

George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...

George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...

George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...